Olopatadine Suppresses the Migration of THP-1 Monocytes Induced by S100A12 Protein

Olopatadine hydrochloride (olopatadine) is an antiallergic drug with histamine H1 receptor antagonistic activity. Recently, olopatadine has been shown to bind to S100A12 which is a member of the S100 family of calcium-binding proteins, and exerts multiple proinflammatory activities including chemota...

Full description

Saved in:
Bibliographic Details
Main Authors: Kazuya Kishimoto, Satoshi Kaneko, Kenji Ohmori, Tadafumi Tamura, Kazuhide Hasegawa
Format: Article
Language:English
Published: Wiley 2006-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/MI/2006/42726
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549452911476736
author Kazuya Kishimoto
Satoshi Kaneko
Kenji Ohmori
Tadafumi Tamura
Kazuhide Hasegawa
author_facet Kazuya Kishimoto
Satoshi Kaneko
Kenji Ohmori
Tadafumi Tamura
Kazuhide Hasegawa
author_sort Kazuya Kishimoto
collection DOAJ
description Olopatadine hydrochloride (olopatadine) is an antiallergic drug with histamine H1 receptor antagonistic activity. Recently, olopatadine has been shown to bind to S100A12 which is a member of the S100 family of calcium-binding proteins, and exerts multiple proinflammatory activities including chemotaxis for monocytes and neutrophils. In this study, we examined the possibility that the interaction of olopatadine with S100A12 inhibits the proinflammatory effects of S100A12. Pretreatment of olopatadine with S100A12 reduced migration of THP-1, a monocyte cell line, induced by S100A12 alone, but did not affect recombinant human regulated upon activation, normal T cell expressed and secreted (RANTES)-induced migration. Amlexanox, which also binds to S100A12, inhibited the THP-1 migration induced by S100A12. However, ketotifen, another histamine H1 receptor antagonist, had little effect on the activity of S100A12. These results suggest that olopatadine has a new mechanism of action, that is, suppression of the function of S100A12, in addition to histamine H1 receptor antagonistic activity.
format Article
id doaj-art-966632ed7c994bb0a970b11d4b1a9408
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2006-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-966632ed7c994bb0a970b11d4b1a94082025-02-03T06:11:15ZengWileyMediators of Inflammation0962-93511466-18612006-01-01200610.1155/MI/2006/4272642726Olopatadine Suppresses the Migration of THP-1 Monocytes Induced by S100A12 ProteinKazuya Kishimoto0Satoshi Kaneko1Kenji Ohmori2Tadafumi Tamura3Kazuhide Hasegawa4Pharmaceutical Research Center, Kyowa Hakko Kogyo Co, Ltd, 1188 Shimotogari, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8731, JapanPharmaceutical Research Center, Kyowa Hakko Kogyo Co, Ltd, 1188 Shimotogari, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8731, JapanPharmaceutical Research Center, Kyowa Hakko Kogyo Co, Ltd, 1188 Shimotogari, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8731, JapanPharmaceutical Research Center, Kyowa Hakko Kogyo Co, Ltd, 1188 Shimotogari, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8731, JapanPharmaceutical Research Center, Kyowa Hakko Kogyo Co, Ltd, 1188 Shimotogari, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8731, JapanOlopatadine hydrochloride (olopatadine) is an antiallergic drug with histamine H1 receptor antagonistic activity. Recently, olopatadine has been shown to bind to S100A12 which is a member of the S100 family of calcium-binding proteins, and exerts multiple proinflammatory activities including chemotaxis for monocytes and neutrophils. In this study, we examined the possibility that the interaction of olopatadine with S100A12 inhibits the proinflammatory effects of S100A12. Pretreatment of olopatadine with S100A12 reduced migration of THP-1, a monocyte cell line, induced by S100A12 alone, but did not affect recombinant human regulated upon activation, normal T cell expressed and secreted (RANTES)-induced migration. Amlexanox, which also binds to S100A12, inhibited the THP-1 migration induced by S100A12. However, ketotifen, another histamine H1 receptor antagonist, had little effect on the activity of S100A12. These results suggest that olopatadine has a new mechanism of action, that is, suppression of the function of S100A12, in addition to histamine H1 receptor antagonistic activity.http://dx.doi.org/10.1155/MI/2006/42726
spellingShingle Kazuya Kishimoto
Satoshi Kaneko
Kenji Ohmori
Tadafumi Tamura
Kazuhide Hasegawa
Olopatadine Suppresses the Migration of THP-1 Monocytes Induced by S100A12 Protein
Mediators of Inflammation
title Olopatadine Suppresses the Migration of THP-1 Monocytes Induced by S100A12 Protein
title_full Olopatadine Suppresses the Migration of THP-1 Monocytes Induced by S100A12 Protein
title_fullStr Olopatadine Suppresses the Migration of THP-1 Monocytes Induced by S100A12 Protein
title_full_unstemmed Olopatadine Suppresses the Migration of THP-1 Monocytes Induced by S100A12 Protein
title_short Olopatadine Suppresses the Migration of THP-1 Monocytes Induced by S100A12 Protein
title_sort olopatadine suppresses the migration of thp 1 monocytes induced by s100a12 protein
url http://dx.doi.org/10.1155/MI/2006/42726
work_keys_str_mv AT kazuyakishimoto olopatadinesuppressesthemigrationofthp1monocytesinducedbys100a12protein
AT satoshikaneko olopatadinesuppressesthemigrationofthp1monocytesinducedbys100a12protein
AT kenjiohmori olopatadinesuppressesthemigrationofthp1monocytesinducedbys100a12protein
AT tadafumitamura olopatadinesuppressesthemigrationofthp1monocytesinducedbys100a12protein
AT kazuhidehasegawa olopatadinesuppressesthemigrationofthp1monocytesinducedbys100a12protein